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Background and purpose: Endothelial derivatives of human pluripotent stem cells may offer 
regenerative treatments in ischemic cardiovascular diseases. Here we studied differentiation 
conditions toward mature endothelial population as well as fate and function of these cells during 
3D culturing. 
Methods and results: To optimize endothelial development, human embryonic stem cells 
(hESC) were differentiated via embryoid body (EB) or monolayer method under normoxic and 
hypoxic conditions. CD31-positive endothelial cells (EC) were sorted by FACS and compared 
with human induced pluripotent stem cell-derived endothelial cells (hIPSC-EC) and human adult 
coronary arterial endothelial cells (HCAEC). Both hESC-EC and hIPSC-EC showed mature 
endothelial characteristics such as cobblestone pattern, ac-LDL uptake, and tube formation in 
vitro. Proteome profiling revealed high abundance of angiogenesis-related proteins in cell lysates 
and supernatant. As assessed by qPCR, angiopoietin2 mRNA levels increased in hESC-EC when 
differentiated via EB method (EB in normoxia 353.17±86.29; EB in hypoxia 323.89±86.63, 
monolayer 27.20±9.92 vs. hESC, p<0.001). Expressions of arterial (EphrinB2, Notch1–2) and 
venous (EphB4) endothelial markers were increased, suggesting the presence of mixed 
endothelial population in culture. However, no significant differences were found in ratio of 
arterial and venous subpopulations in the different developmental protocols. For engineering 3D 
vascular constructs decellularised human aortic slices (300μm) were repopulated with hESC-EC 
and hIPSC-EC and cells remained viable on engineered matrices in vitro. Engineered bioscaffold 
were incubated with platelet rich plasma from healthy adults. 3D culture conditions activated 
antiplatelet effects of the cells (as shown by secreted levels of chemokine Rantes (pg/ml): hESC-
EC 229.6±37.9, hESC-EC on bioscaffold 83.6±52.1; hIPSC-EC 234.9±22.8, hIPSC-EC on 
bioscaffold 127.9±63.6, p<0.01, n=6). 
Conclusions: Differentiation conditions modulate endothelial development and angiogenic gene 
expression. 3D culturing increased antiplatelet effects. Functionally active endothelial 
derivatives of human pluripotent stem cells promises vascular tissue engineering for therapeutic 
purposes. 
 
 
 
